Watch Ticker

ALX Oncology Holdings Inc. Common Stock

Go to ALX Oncology Holdings Inc. Common Stock Website

$0.57

0.05 (9.98%)

Live

Previous Close

$0.5181

Day Range

$0.51 - $0.5895

Previous Day Range

$0.51 - $0.55

Market Cap

$27.7 million USD

Day Vol.

313714

Previous Day Vol.

415913

Currency

USD

Primary Exchange

Nasdaq

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - ALX Oncology to Host R&D Webcast Event Highlighting its Novel EGFR Targeting Antibody-Drug Conjugate, ALX2004, on May 20, 2025

ALX Oncology announced it will host a webcast event on May 20, 2025, to provide an update on its investigational antibody-drug conjugate ALX2004, which is designed to treat EGFR-expressing tumors.

Related tickers: ALXO.

Read Full Article

Prnewswire - Why the Global Cancer Market Could Surpass $900 Billion--And the Stocks Leading the Charge

The global cancer market is projected to surpass $900 billion by 2034, driven by advancements in cancer treatments from biotech companies like Oncolytics Biotech, Exelixis, Cardiff Oncology, ALX Oncology, and Verastem.

Related tickers: ONCY, EXEL, CRDF, ALXO, VSTM.

Read Full Article

Trending Tickers

Please sign in to view